The North America Animal Sedative Market is projected to witness market growth of 5.2% CAGR during the forecast period (2024-2031).
The US market dominated the North America Animal Sedative Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $130.74 millions by 2031. The Canada market is experiencing a CAGR of 7.2% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.7% during (2024 - 2031).
Animal sedatives are pharmaceutical drugs used to induce sedation or calmness in animals for various medical procedures, handling, or behavioral management. These medications act on the central nervous system, producing effects such as relaxation, reduced anxiety, muscle relaxation, and, in some cases, sleepiness. Veterinarians commonly administer them to facilitate safe and stress-free handling of animals during examinations, surgeries, diagnostic procedures, and transportation.
In addition, animal sedatives are essential pharmaceuticals used across diverse sectors of veterinary care to manage animals' behavior and physical responses during medical procedures, examinations, and handling. Sedatives are commonly used in veterinary clinics and hospitals to calm pets during routine examinations, vaccinations, dental cleanings, and minor surgical procedures.
As the pet population in Canada grows, so does the need for veterinary care, including procedures that may require sedation. According to the Canadian Animal Health Institute, the number of dogs and cats in Canada increased between 2020 and 2022, rising from 8.1 million to 8.5 million for cats and from 7.7 million to 7.9 million for dogs. With more Canadians owning pets, there is a corresponding expansion in the number of veterinary clinics, hospitals, and practices across the country. This expansion increases the availability of veterinary services and drives the demand for pharmaceutical products, including sedatives, used in these facilities. Also, 3% rise from 58% in 2020 to 61% in 2022 in the number of cats reported to have visited a vet in the previous 12 months. Hence, increasing clinical visits and the rising population of pets in the region are driving the market's growth.
The US market dominated the North America Animal Sedative Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $130.74 millions by 2031. The Canada market is experiencing a CAGR of 7.2% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.7% during (2024 - 2031).
Animal sedatives are pharmaceutical drugs used to induce sedation or calmness in animals for various medical procedures, handling, or behavioral management. These medications act on the central nervous system, producing effects such as relaxation, reduced anxiety, muscle relaxation, and, in some cases, sleepiness. Veterinarians commonly administer them to facilitate safe and stress-free handling of animals during examinations, surgeries, diagnostic procedures, and transportation.
In addition, animal sedatives are essential pharmaceuticals used across diverse sectors of veterinary care to manage animals' behavior and physical responses during medical procedures, examinations, and handling. Sedatives are commonly used in veterinary clinics and hospitals to calm pets during routine examinations, vaccinations, dental cleanings, and minor surgical procedures.
As the pet population in Canada grows, so does the need for veterinary care, including procedures that may require sedation. According to the Canadian Animal Health Institute, the number of dogs and cats in Canada increased between 2020 and 2022, rising from 8.1 million to 8.5 million for cats and from 7.7 million to 7.9 million for dogs. With more Canadians owning pets, there is a corresponding expansion in the number of veterinary clinics, hospitals, and practices across the country. This expansion increases the availability of veterinary services and drives the demand for pharmaceutical products, including sedatives, used in these facilities. Also, 3% rise from 58% in 2020 to 61% in 2022 in the number of cats reported to have visited a vet in the previous 12 months. Hence, increasing clinical visits and the rising population of pets in the region are driving the market's growth.
List of Key Companies Profiled
- Koninklijke Philips N.V.
- Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Visiopharm A/S
- Paige AI, Inc.
- PathAI, Inc.
- Aiforia Technologies Plc
- Indica Labs, Inc.
- Optrascan, Inc. (Optra Ventures, LLC)
- MindPeak GmbH
Market Report Segmentation
By Route of Administration- Parenteral
- Oral
- Dogs
- Cats
- Horses
- Others
- Alpha-2 Adrenergic Receptor Agonists
- Phenothiazines
- Benzodiazepines
- Butyrophenones
- Others
- Hospitals
- Specialty Centers
- Surgical
- Diagnostic
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Animal Sedative Market by Route of Administration
Chapter 5. North America Animal Sedative Market by Animal Type
Chapter 6. North America Animal Sedative Market by Drug Class
Chapter 7. North America Animal Sedative Market by End Use
Chapter 8. North America Animal Sedative Market by Application
Chapter 9. North America Animal Sedative Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Zoetis, Inc.
- Virbac
- Dechra Pharmaceuticals PLC
- Merck & Co., Inc.
- Bimeda, Inc.
- Ouro Fino Saude Animal Participacoes S.A.
- vetcare. fi.
- Chanelle Pharma (Exponent)
- Randlab Australia Pty Ltd.
- Troy Laboratories Pty Ltd.
Methodology
LOADING...
